BioSpace News Archive

Opiant Pharmaceuticals, Inc. (Opiant) (NASDAQ: OPNT) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Opiant’s pipeline candidate OPNT004 (drinabant) for the treatment of cannabinoid hyperemesis syndrome (CHS), a condition among cannabis users that leads to repeated and severe bouts of vomiting.

BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the quarter ended June 30, 2022.

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will present a company update at the following investor conferences:

Invacare Corporation (NYSE: IVC) today announced that it has entered into a cooperation agreement with its largest shareholder, Azurite Management LLC (“Azurite”), which currently owns approximately 10.3% of the company’s outstanding shares as of June 30, 2022.

Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK), today announced the appointments of Eleanor (Ellee) de Groot, Ph.D., as Chief Technology Officer and Aleksandar Skuban, M.D., as Central Nervous System (CNS) Diseases Therapy Area Head.

Assertio Holdings, Inc., a specialty pharmaceutical company offering differentiated products to patients, announced the pricing of its offering of $60 million aggregate principal amount of 6.50% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today reported financial results for the second quarter of 2022 ended June 30, 2022, and announced a business update conference call to be held on Tuesday, August 23, 2022, at 8:30am ET.

Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.95 per share to $2.15 per share.

BrainChip Holdings Ltd (ASX:BRN)(OTCQX:BRCHF)(ADR:BCHPY), and Edge Impulse, the leading development platform for machine learning (ML) on edge devices, are hosting the webinar “Bringing development of BrainChip Akida Neuromorphic models to all using Edge Impulse” August 24 at 11 a.m. PDT.

Alcon (SIX/NYSE: ALC), and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”), today announced the companies have entered into a definitive merger agreement through which Alcon will acquire Aerie.